Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.91 USD | -3.64% | -2.02% | -25.00% |
Apr. 18 | Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board | CI |
Mar. 12 | Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 92.83M |
---|---|---|---|---|---|
Net income 2024 * | -14M | Net income 2025 * | -15M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.61
x | P/E ratio 2025 * |
-6.47
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.09% |
Latest transcript on Anixa Biosciences, Inc.
1 day | -3.64% | ||
1 week | -2.02% | ||
Current month | -2.02% | ||
1 month | -9.06% | ||
3 months | -34.75% | ||
6 months | -4.59% | ||
Current year | -25.00% |
Managers | Title | Age | Since |
---|---|---|---|
Amit Kumar
CEO | Chief Executive Officer | 59 | 12-10-31 |
Michael Catelani
DFI | Director of Finance/CFO | 57 | 16-10-31 |
Pamela Garzone
PRN | Corporate Officer/Principal | 69 | 21-09-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Titterton
BRD | Director/Board Member | 79 | 99-06-30 |
Amit Kumar
CEO | Chief Executive Officer | 59 | 12-10-31 |
Emily Gottschalk
BRD | Director/Board Member | 63 | 19-10-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 2.91 | -3.64% | 61,801 |
24-05-06 | 3.02 | +2.72% | 67,858 |
24-05-03 | 2.94 | -1.01% | 115,775 |
24-05-02 | 2.97 | -3.88% | 52,136 |
24-05-01 | 3.09 | +4.04% | 58,633 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.00% | 92.83M | |
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+49.62% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B |
- Stock Market
- Equities
- ANIX Stock